English | 简体中文 | 繁體中文 | 한국어
 All Press Releases

CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 22:00 HKT
Revolutionary Blockchain-based Dancing Platform, DANSA to Be Launched Soon
Aug 10, 2022 21:00 HKT
Revolutionary Blockchain-based Dancing Platform, DANSA to Be Launched Soon
Aug 10, 2022 21:00 HKT
CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 21:00 HKT
CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 21:00 HKT
创科实业于二零二二年上半年创下骄人业绩
Aug 10, 2022 19:27 HKT
創科實業於二零二二年上半年創下驕人業績
Aug 10, 2022 19:26 HKT
TTI Delivers Strong 2022 First Half Results
Aug 10, 2022 19:25 HKT
TOYOTA、9月 生産計画について発表
Aug 10, 2022 17:00 HKT
Honda、2022年度第1四半期決算および通期業績見通しを発表
Aug 10, 2022 15:30 HKT
三菱自動車、MIRAI-LABO、電動車の使用済みバッテリーを用いた自律型街路灯の開発検討を開始
Aug 10, 2022 15:00 HKT
《滨海宁波·扬帆世界》邓蓓佳独家专访周莉莉:香港当好超级联系人 联合国秘书长特使建言献策
Aug 10, 2022 13:59 HKT
《濱海寧波·揚帆世界》鄧蓓佳獨家專訪周莉莉:香港當好超級聯繫人 聯合國秘書長特使建言獻策
Aug 10, 2022 13:58 HKT
Bintai Kinden to Market O&G Equipment in Indonesia
Aug 10, 2022 13:00 HKT
Society Pass backed Thoughtful Media Group Announces New CEO and Vision to be the Leader in Digital and Social Commerce in SEA
Aug 10, 2022 12:00 HKT
India's top BFSI experts Unite to Reshape India's Banking Landscape at #TresconBFSI
Aug 09, 2022 20:42 HKT
SKYX Achieves Historic U.S. Standardization Approval Vote - a Major Milestone Towards Mandatory Status for Safety of Consumers and Professionals
Aug 09, 2022 20:31 HKT
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans
Aug 09, 2022 20:30 HKT
德勤中國發佈2022財年社會影響力報告
Aug 09, 2022 17:57 HKT
Eisai and Lifenet Enter Into Capital and Business Alliance Agreement Aimed at Building Ecosystem to Reduce Burden of Medical and Nursing Care
Aug 09, 2022 17:09 HKT
Next >>
 Releases By Language
All
English
Indonesian
Japanese
Korean
Thai
Trad. Chinese
Simp. Chinese
Vietnamese
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: